(0)サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1683381

鼓膜切開術の世界市場：2025年～2033年

Global Tympanostomy Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.63円
鼓膜切開術の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の鼓膜切開術の市場規模は、2024年に1億1,070万米ドルに達し、2033年には1億1,530万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは3.8％になる見込みです。

鼓膜切開術は、鼓膜（鼓膜）に小さな切開を加えて中耳の液体を排出し、圧力を緩和する外科的処置であり、慢性中耳炎や滲出性中耳炎のような状態を治療するために一般的に使用されます。鼓膜切開チューブまたはイヤーチューブを鼓膜に挿入することで、手術中も中耳の排液と換気を継続的に行うことができます。

これらのチューブは通常、シリコン、ステンレス、プラスチックなどの素材でできており、患者のニーズに応じてさまざまなサイズがあります。鼓膜切開チューブの最も一般的な種類は、標準チューブ、抗菌チューブ、延長使用チューブで、それぞれ異なる条件や使用期間に合わせて設計されています。

中耳炎の罹患率の上昇が鼓膜切開市場の成長を促進すると予想されます。中耳炎は、特に小児で非常に多く発生しています。例えば、米国国立衛生研究所によると、2023年には約80%の小児が生涯に少なくとも1回は中耳炎を経験し、80%から90%の小児が就学前に滲出性中耳炎に遭遇するといいます。発症のピークは生後6～12ヵ月であり、この疾患の早期発症が強調されています。中耳炎は小児における最も一般的な耳の感染症であるため、鼓膜切開術のような効果的な治療に対する大きな需要があります。

さらに、この処置は、中耳炎を繰り返す子どもや、慢性的な耳の感染症の既往歴がある子ども、あるいは口蓋裂や免疫不全などの疾患がある子どもにとって特に有益です。世界の症例数の増加、特に小児人口の増加に伴い、鼓膜切開術の需要は拡大し、市場をさらに牽引すると予想されます。

鼓膜切開術に関連するリスクや合併症（感染症、チューブの脱落、鼓膜穿孔、聴力の問題の可能性など）は、ヘルスケアプロバイダーや患者の間に消極的な態度を引き起こし、鼓膜切開術市場の成長を妨げる可能性があります。これらの潜在的な副作用は、医療費の増加、追加治療、患者の不快感を招き、処置の採用を妨げる可能性があります。その結果、患者や臨床医はリスクの少ない代替治療を選ぶようになり、鼓膜切開術の市場全体の需要が鈍化する可能性があります。

当レポートでは、世界の鼓膜切開術市場について調査し、市場の概要とともに、製品タイプ別、使用法別、材料タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 鼓膜切開術市場、製品タイプ別

  • 鼓室チューブ
  • チューブアプリケーター/インサーター
  • その他

第6章 鼓膜切開術市場、使用法別

  • 短期チューブ
  • 長期チューブ

第7章 鼓膜切開術市場、材料タイプ別

  • チタン
  • シリコーン
  • フッ素樹脂
  • ステンレス鋼
  • その他

第8章 鼓室切開術市場、用途別

  • 慢性中耳炎
  • 再発性急性中耳炎
  • 耳管機能障害
  • その他

第9章 鼓膜切開術市場、エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第10章 鼓室切開術市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

第12章 企業プロファイル

  • Cyberdyne Care Robotics GmbH
  • Medasil Surgical Limited
  • Preceptis Medical
  • Grace Medical
  • EON Meditech
  • SPIGGLE &THEIS Medizintechnik GmbH
  • Olympus
  • AventaMed DAC
  • Summit Medical LLC.
  • Adept Medical

第13章 仮定と調査手法

第14章 付録

目次
Product Code: MD1388

The global tympanostomy market reached US$ 110.7 million in 2024 and is expected to reach US$ 115.3 million by 2033, growing at a CAGR of 3.8% during the forecast period 2025-2033.

Tympanostomy is a surgical procedure in which a small incision is made in the eardrum (tympanic membrane) to drain fluid from the middle ear and relieve pressure, commonly used to treat conditions like chronic otitis media or otitis media with effusion. The tympanostomy tube or ear tube is inserted into the eardrum to allow continuous drainage and ventilation of the middle ear during the procedure.

These tubes are typically made of materials like silicone, stainless steel, or plastic and come in various sizes depending on the patient's needs. The most common types of tympanostomy tubes are standard tubes, antibacterial tubes, and extended-use tubes, each designed for different conditions and duration of use.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Otitis Media

The growing incidence of otitis media is expected to drive the growth of the tympanostomy market. Otitis media, particularly in children, is highly prevalent. For instance, according to the National Institute of Health, in 2023, approximately 80% of children experience at least one case during their lifetime, and 80% to 90% of children encounter otitis media with effusion before school age. The peak incidence occurs between six and twelve months of life, highlighting the early onset of this condition. As the most common ear infection in children, otitis media creates a substantial demand for effective treatments, such as tympanostomy, which helps alleviate chronic ear infections by draining fluid and preventing further complications.

Additionally, the procedure is particularly beneficial for children with recurrent otitis media, a history of chronic ear infections, or those with conditions such as cleft palate or immunodeficiency, which increase susceptibility to the condition. With the rising number of cases globally, especially in pediatric populations, the demand for tympanostomy procedures is expected to grow, further driving the market.

Risks and Complications

The risks and complications associated with tympanostomies, such as infections, tube dislodgment, eardrum perforation, and potential hearing issues, may hinder the growth of the tympanostomy market by causing reluctance among healthcare providers and patients. These potential adverse effects can lead to increased medical costs, additional treatments, and patient discomfort, which may discourage the adoption of the procedure. As a result, patients and clinicians might opt for alternative treatments with fewer risks, slowing the overall market demand for tympanostomy procedures.

Segment Analysis

The global tympanostomy market is segmented based on product type, usability, material type, application, end-user and region.

Tympanostomy tubes in the product type segment are expected to dominate the tympanostomy market.

Tympanostomy tubes are expected to dominate the tympanostomy market due to their essential role in the treatment of chronic otitis media and otitis media with effusion, particularly in pediatric populations. These small, inserted tubes allow for the continuous drainage of fluid from the middle ear, helping to prevent the buildup that causes pain and infection. As the prevalence of ear infections remains high, especially among children, the demand for tympanostomy tubes continues to rise.

Furthermore, advancements in tube materials, rising product launches, and innovative design have made these devices even more effective and desirable in clinical practice. For instance, in June 2024, AventaMed, a KARL STORZ Company, proudly announced the launch of the Solo+, a groundbreaking, single-use ear tube device designed to transform the most frequently performed pediatric ENT surgery. This innovative device has achieved significant regulatory milestones, including certification under the European Medical Device Regulation (MDR) and FDA 510(k) clearance for patients aged six months to 24 months.

Additionally, the increasing preference for minimally invasive treatments and the proven success of tympanostomy tubes in managing recurrent ear infections make them the preferred choice in otolaryngology.

Geographical Analysis

North America is expected to dominate the tympanostomy market

North America is expected to dominate the tympanostomy market due to several key factors specific to the region. The high prevalence of otitis media in children is a major driver of market growth. There is a substantial demand for effective treatments like tympanostomy, especially for those with recurrent or chronic ear infections in the region. Additionally, pediatric patients in North America often have access to timely interventions, which increases the number of procedures performed annually.

The region also benefits from strong physician expertise and a high rate of procedural adoption, as tympanostomy is a widely recognized and commonly performed procedure for managing middle ear infections. Moreover, the availability of advanced tympanostomy tubes and continuous development in their design and materials further drive the growth of the market in North America. Companies in the region are taking initiatives for their product expansion in the region to reach a large population. For instance, in March 2024, Preceptis Medical launched its new website for the Hummingbird Tympanostomy Tube System (TTS). The launch of this online resource highlights the company's growth and the rising demand from both parents and physicians for the Hummingbird in-office ear tube procedure.

Competitive Landscape

The global market players in the tympanostomy market are Smith+Nephew, Medasil Surgical Limited, Preceptis Medical, Grace Medical, EON Meditech, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, AventaMed DAC, Summit Medical LLC. and Adept Medical, among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global tympanostomy market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Usability
  • 2.5. Snippet by Material Type
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Incidence of Otitis Media
      • 3.1.1.2. Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Risks and Complications
      • 3.1.2.2. Availability of Alternative Treatments
    • 3.1.3. Opportunity
      • 3.1.3.1. New Product Launches and Approvals
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Tympanostomy Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Tympanostomy Tubes*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Tube Applicators / Inserters
  • 5.4. Others

6. Tympanostomy Market, By Usability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 6.1.2. Market Attractiveness Index, By Usability
  • 6.2. Short-term Tubes*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Long-term Tubes

7. Tympanostomy Market, By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Titanium*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Silicone
  • 7.4. Fluoroplastic
  • 7.5. Stainless Steel
  • 7.6. Others

8. Tympanostomy Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Chronic Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Recurrent Acute Otitis Media
  • 8.4. Eustachian Tube Dysfunction
  • 8.5. Others

9. Tympanostomy Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Tympanostomy Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Mexico
      • 10.4.8.2. Brazil
      • 10.4.8.3. Argentina
      • 10.4.8.4. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Cyberdyne Care Robotics GmbH*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Medasil Surgical Limited
  • 12.3. Preceptis Medical
  • 12.4. Grace Medical
  • 12.5. EON Meditech
  • 12.6. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.7. Olympus
  • 12.8. AventaMed DAC
  • 12.9. Summit Medical LLC.
  • 12.10. Adept Medical

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us